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The reduction of oxidative stress is suggested to be one of the main mechanisms to explain the benefits of subnormothermic
perfusion against ischemic liver damage. In this study we investigated the early cellular mechanisms induced in isolated
rat livers after 15min perfusion at temperatures ranging from normothermia (37∘C) to subnormothermia (26∘C and 22∘C).
Subnormothermic perfusion was found to maintain hepatic viability. Perfusion at 22∘C raised reduced glutathione levels and
the activity of glutathione reductase; however, lipid and protein oxidation still occurred as determined by malondialdehyde,
4-hydroxynonenal-protein adducts, and advanced oxidation protein products. In livers perfused at 22∘C the lysosomal and
ubiquitin proteasome system (UPS) were both activated. The 26S chymotrypsin-like (𝛽5) proteasome activity was significantly
increased in the 26∘C (46%) and 22∘C (42%) groups. The increased proteasome activity may be due to increased Rpt6 Ser120
phosphorylation, which is known to enhance 26S proteasome activity. Together, our results indicate that the early events produced
by subnormothermic perfusion in the liver can induce oxidative stress concomitantly with antioxidant glutathione preservation
and enhanced function of the lysosomal and UPS systems. Thus, a brief hypothermia could trigger antioxidant mechanisms and
may be functioning as a preconditioning stimulus.
1. Introduction
Amajor clinical problem in liver surgery and transplantation
is damage due to transient ischemia and reperfusion [1–
3]. The pathological process involves a variety of cellular
dysfunctions caused by increased production of reactive oxy-
gen species and inflammatory responses [4]. Several studies
suggest that the induction of mild (32–35∘C) to moderate
(28–32∘C) hypothermia may attenuate the progression of
liver damage against ischemia [1, 5, 6]. Moreover, perfusion
in ex vivo machines resulted in improved viability at sub-
normothermic temperatures (20-21∘C), in both livers from
experimental animals [7–11] and from humans [12, 13].These
authors also found thatmany livers whichwould be discarded
due to their low quality could be rescued for transplantation
thanks to the restorative effects of subnormothermic perfu-
sion.
There is growing interest in the use of hypothermia to
prevent ischemic damage in clinical and experimental trials
[14]. The protective effects of hypothermia are suggested to
primarily be a consequence of decreased cellularmetabolism,
thus conserving ATP levels [15]. This proposal implies a
passive method for hypothermia-induced protection and
does not explain the wide role of therapeutic hypothermia
against many injuries and in different tissues. Reduction
of oxidative stress, as observed in ischemic cardiomyocytes
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[16], and attenuation in the consumption of endogenous
antioxidants, as seen in hypoxic brains [17, 18], could be two
additional mechanisms.
In the liver, the observed hepatoprotective effects of
hypothermia against ischemia include prolonging survival,
attenuation of liver damage [1, 5], suppressed reactive oxygen
species, and improved sinusoidal perfusion [19, 20]. Mild
hypothermia also attenuated the progression of liver injury
induced by other agents, such as acetaminophen in mice [21]
and hepatocarcinogenesis in rats [22].
Cellular pathways affected by hypothermia have been
reviewed by our group and others [23–25].Most of the studies
cited in these reviews focused on mechanisms related to
inflammation, free radicals, or apoptosis, and consistently
demonstrated that when hypothermia is induced before
ischemic, hypoxic, or toxic episodes, it is able to reduce
deleterious pathways while enhancing protective events.
These effects of hypothermia lead us to consider whether
hypothermia could have a more active role in preventing
damage through triggering antioxidative mechanisms of cell
protection. Given the recent contributions that perfusion
of isolated livers at subnormothermic temperature protects
cellular integrity [9, 12], we investigated isolated perfused rat
livers (IPRL) at a range of temperatures from normothermia
(37∘C) to subnormothermia (26∘C and 22∘C) for a brief
period of time (15 minutes) and then investigated oxidative
damage parameters and antioxidant defenses. Jung et al. [26]
identified three lines of defense against oxidative stress: the
first includes antioxidant molecules (such as glutathione),
the second includes enzymatic antioxidants, and the third
involves repair system proteins, including the proteolytic
pathways. Of the two systems of intracellular proteolysis, the
lysosomal system plays an important role in the degradation
ofmembrane-bound proteinswhile the ubiquitin proteasome
system (UPS) is widely recognized as the main system
for degradation of cytosolic proteins [27, 28]. Our results
suggest hypothermia limits ischemic damage by activating
protectivemechanisms in two of the oxidative stress defensive
categories: antioxidant molecules and repair system proteins.
We detected increased glutathione levels and proteolytic
activity which may limit ischemia induced oxidative damage.
2. Materials and Methods
2.1. Animals and Liver Isolation and Perfusion. Adult male
Sprague-Dawley rats (225–250 g body weight) were used in
this study. Rats were fasted overnight and had free access to
water. Rats were anesthetized with i.p. sodium pentobarbital
(65mg/Kg). Heart failure was induced by incision in the
diaphragm and the liver was isolated and connected for
perfusion in a nonrecirculating IPRL system at a flow rate of
3mL/min/g liver with Krebs-Henseleit buffer (KHB) (mM):
118 NaCl, 4.7 KCl, 1.2 MgSO
4
, 1.2 KH
2
PO
4
, 2.5 CaCl
2
, 25
NaHCO
3
, 20 Hepes (pH 7.4), aerated with 95% O
2
, and 5%
CO
2
[29]. The procedure was approved by the University
of Barcelona Institutional Committee of Animal Care and
Research and followed European Community guidelines.
Livers were perfused at 37∘C for 15min to stabilize. Then
they were randomly distributed in the three experimental
groups that were perfused at 37∘C, 26∘C, or 22∘C for 15min
(total time of experiment lasting 30min). As an index of
cellular injury, plasma alanine aminotransferase (ALT) was
measured in the effluent using a commercial kit (BioSystems,
Barcelona, Spain). After perfusion, liverswere frozen in liquid
nitrogen and stored at −80∘C until analysis.
Nitric oxide (NO) regulates the hepatic microvascular
perfusion through its vasodilatory effect and through its
anti-inflammatory actions [30]. NO levels were measured
as nitrate plus nitrite in liver homogenates in 10% (w/v)
PBS, centrifuged at 2000×g for 5min, and ultrafiltered by
means of a 30 kDamolecular weight cut-off filter. In the assay,
nitrate was converted to nitrite using nitrate reductase and
total nitrite was measured using the Griess reaction and a
colorimetric assay kit (Cayman Chemical Co., Ann Arbor,
MI, USA) and expressed as nmol/mg protein.
All other chemicals were purchased from Sigma-Aldrich
Chemical.
2.2. Oxidant Assays. Lipid peroxidation in the liver was
determined as the end product malondialdehyde (MDA)
by thiobarbituric reactive substances (TBARS) assay [31].
Liver was homogenized with a teflon bar in 10% (w/v)
RIPA solution, (Tris 50mM pH 7.4, 1% Triton X-100, NaCl
150mM, NaF 5mM, 0.1% sodium dodecyl sulphate, and 1%
sodium deoxycholate) with antiprotease solution (aprotinin
at 1.7mg/mL, 2 𝜇g/mL pepstatin, 2𝜇g/mL leupeptin and
1mMphenylmethylsulfonyl fluoride, and sodium orthovana-
date at 1mM).The suspension was centrifuged at 2000×g for
5min and the pellet discarded. The formation of MDA-TBA
adduct was fluorometrically measured at an excitation wave-
length of 515 nm and an emission wavelength of 550 nm.The
calibration curve was determined using tetraethoxypropane.
Values are expressed as TBARS in nmol/mg protein.
Advanced oxidation protein products (AOPP) have been
identified as a biomarker of oxidative damage to proteins,
detecting dityrosine-containing and cross-linking protein
products, but also a novel mediator of inflammation [32].
AOPP in liver homogenates were assayed by amodification of
Witko–Sarsat’s method [32, 33]. The formation of AOPP was
spectrophotometrically measured at 340 nm and results were
obtained through a standard calibration curve using 100𝜇L of
chloramine-T solution (0–100𝜇mol/L). AOPP concentration
was expressed as 𝜇mol/L of chloramine-T equivalents.
2.3. Total ProteinDetermination. The total liver proteins were
determined using the Bradford protein assay [34].
2.4. Antioxidant Assays. Reduced (GSH) and oxidized glu-
tathione (GSSG) were measured in the liver extracts using
the procedure described byHissin andHilf [35] andmodified
by Alva et al. [36]. Tissue was homogenized in cold buffer
containing 5mm phosphate-EDTA buffer (pH 8.0) and 25%
HPO
3
. The homogenates were ultracentrifuged at 100,000×g
and 4∘C for 30min, and the resulting supernatant was used
to determine GSH and GSSG concentrations, using the
fluorescent probe o-phthalaldehyde. Fluorescence was deter-
mined at a wavelength emission of 420 nm and excitation at
350 nm.
Oxidative Medicine and Cellular Longevity 3
Glutathione reductase (GSH-R, EC 1.6.4.2) is a flavo-
protein that catalyzes the NADPH-dependent reduction of
oxidized glutathione (GSSG) to reduced glutathione (GSH).
For GSH-R determination, tissue was homogenized in cold
buffer (50mM potassium phosphate, pH 7.5, 1mM EDTA)
and centrifuged at 10,000×g for 15min (4∘C). The resulting
supernatant was used to measure GSH-R activity with Cay-
man Chemical Glutathione Reductase Assay Kit (Cayman
Chemical Co., Ann Arbor, MI, USA) by measuring the rate
of NADPHoxidation.The oxidation of NADPH toNADP+ is
accompanied by a decrease in absorbance at 340 nm. Results
of GSH-R activity are expressed as mU/mg protein.
2.5. Proteolytic Activity Measurement of Cathepsin B and
Cathepsin L and 26S Proteasome. Proteolytic activities were
measured as previously described by our laboratory [37–
39]. Cathepsin B and Cathepsin L assays were carried out
in a total volume of 100 𝜇L per well in black 96-well plates.
For the cathepsin B activity, protein samples (25𝜇g) were
incubated with 100𝜇M substrate Z-Arg-Arg-AMC (Biomol)
in 44mM potassium phosphate buffer, 6mM sodium phos-
phate, 0.67mM EDTA, and 1.35mM cysteine (pH 6.0). For
cathepsin L activity, protein samples (25𝜇g) were incubated
with 100𝜇M substrate Z-Phe-Arg-AMC (Peptides Interna-
tional, Louisville, KY, USA) in 100mM sodium acetate buffer,
with 1mM EDTA and 1mM DTT (pH 5.5). The assay was
conducted in the absence and presence of a specific inhibitor
to determine specific activity: for cathepsin B, 10 𝜇M CA-
074 (Enzo, Life Sciences, Farmingdale, NY, USA) was used,
and to inhibit cathepsin L, 10 𝜇M Cathepsin L inhibitor
I (Calbiochem, La Jolla, CA, USA) was used. Released
AMC was measured using a Fluoroskan Ascent fluorometer
(Thermo Electron) at 390 nm (excitation wavelength) and
460 nm (emission wavelength) for up to 120min.
The ATP-dependent 26S proteasome activities were mea-
sured in the presence of 0.1mM ATP [40]. Liver cell lysates
were prepared by homogenization in 50mM Tris, 1mM
EDTA, 5mM MgCl
2
, 150mM NaCl, and 1mM DTT, pH 7.5.
The samples were then centrifuged at 12,000×g for 15min
(4∘C) and the supernatants were collected. To analyze the
26S proteasome activity of liver homogenates (24𝜇g/sample),
the fluorescent substrates Z-LLE-AMC 100 𝜇M for 𝛽1, Boc-
LSTR-AMC for 𝛽2, and Suc-LLVY-AMC 100 𝜇M for 𝛽5
were used. Each assay was conducted in the absence and
presence of a specific proteasome inhibitor Z-Pro-Nle-Asp-
H (Enzo) 40 𝜇M for 𝛽1, epoxomicin (Peptides International)
40 𝜇M for 𝛽2, and epoxomicin 10 𝜇M for 𝛽5 to determine
proteasome-specific activity. All the assayswere carried out in
a total volume of 100 𝜇L. Released AMC was measured using
a Fluoroskan Ascent fluorometer (Thermo Electron) at an
excitation wavelength of 390 nm and an emission wavelength
of 460 nm.
2.6. Western Blot Analysis and Quantification. Whole liver
cell lysates were prepared by homogenizing the livers in:
50mM Tris (pH 7.5), 1mM EDTA, 5mM MgCl
2
, 150mM
NaCl, supplemented with DTT, and protease inhibitors
(final concentrations were 10 𝜇g/mL aprotinin, 2𝜇g/mL pep-
statin, 2 𝜇g/mL leupeptin, and 1mM phenylmethylsulfonyl
fluoride). The samples were then centrifuged at 12,000×g for
10min and the protein concentration measured in the super-
natant. Supernatants were treated with Laemmli loading
buffer and 50𝜇g of proteins resolved on SDS-polyacrylamide
(10%) gels and transferred to nitrocellulose. Membranes were
then blocked for 1 h with 3% nonfat dry milk (NFM) in Tris-
buffered saline (TBS) (pH 7.4) containing 0.05% (w/v) Tween
20 (TTBS).Themembraneswerewashed three times in TTBS
and probed overnight with the following primary antibodies:
anti-4-HNE conjugates (Novus Biologicals, Littleton, CO,
USA), anti-ubiquitin (Sigma-Aldrich), anti-Rpt6, phospho
S120 Rpt6 (affinity purified rabbit antibody commercially
made by 21st Century Biochemicals), anti-Rpt1, and 20S core
subunits (𝛼5/𝛼7, 𝛽1, 𝛽5, 𝛽5i, and 𝛽7) (Enzo life sciences).
Detection was performed with anti-IgG-HRP (Santa Cruz
Biotechnology, Inc., Heidelberg, Germany). The blots were
visualized with enhanced chemiluminescence (SuperSignal
West Pico Chemiluminescent Substrate, Thermo Scientific,
Rockford, IL, USA) and detected and scanned on Fujifilm
LAS-3000 Imager (Fujifilm Corporation, Tokyo, Japan). Dig-
ital imageswere quantified usingQuantityOne software (Bio-
Rad, Hercules, CA, USA) and normalized to 𝛽-actin (Sigma-
Aldrich, MO, USA). Ponceau S staining as a loading control
was used for anti-Rpt6 and phospho S120 Rpt6 western blots
due to high protein load (80 𝜇g) [41].
2.7. Statistical Analysis. Results are expressed as means ±
SEM of six animals. Data were processed using the statistical
software GraphPad InStat (GraphPad Software, Inc., San
Diego, CA,USA).Themeans of the experimental groupswere
analyzed by two-way ANOVA using the Student–Newman–
Keuls test to identify significant differences (when 𝑃 < 0.05)
between the groups.
3. Results
3.1. Subnormothermic Perfusion Preserves Liver Function but
Increases Oxidative Stress and Protein Oxidation. Our results
showed that subnormothermic perfusion preserves liver
integrity and function, as reflected by decreased ALT levels
in the perfusate (Figure 1(a)), and increased NO in liver
(Figure 1(b)). Because NO has an extremely short half-life,
we measured it indirectly by quantifying the final products
of its reaction, nitrates, and nitrites. These levels increased
from 1.48 ± 0.14 at 37∘C to 2.27 ± 0.17 at 26∘C (𝑃 <
0.01) and 1.945 ± 0.14 at 22∘C (𝑃 < 0.05). However
subnormothermia resulted in higher levels of oxidative stress
markers and protein oxidation. One of the effects of oxidative
stress is lipid peroxidation which involves the interaction
of free radicals with polyunsaturated fatty acids. The end
products of lipid peroxidation are reactive aldehydes, such as
malondialdehyde (MDA)measured as thiobarbituric reactive
substances (TBARS) and 4-hydroxynonenal (HNE). Proteins
are particularly susceptible to changes caused by HNE, and
HNE-protein adducts formation plays a significant role in
many cellular processes [42]. We have found increased levels
of TBARS after subnormothermic perfusion at 26∘C (𝑃 <
0.05) (Figure 2(a)) and increased HNE-protein adducts at
both subnormothermic perfusion temperatures (𝑃 < 0.05)
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Figure 1: Temperature effects on the hepatic function of isolated perfused rat (IPR) livers. IPR livers were perfused in a nonrecirculating
system with Krebs-Henseleit buffer at 37∘C for 15min, for stabilization, and then at the indicated temperatures for 15min more. Results show
cell viability by ALT assay in the perfusate (a) and NO production in liver homogenates (b). Values expressed as mean ± SEM of 𝑛 = 6.
Significant differences from livers perfused at 37∘C: ∗𝑃 < 0.05 and ∗∗𝑃 < 0.01.
(Figure 2(b)). Oxidation induces several modifications in
proteins that can lead to new compounds and modified
structures. AOPP, whichmeasures dityrosine-containing and
cross-linking protein products, increased by 27% in livers
from both subnormothermic perfusion ranges (𝑃 < 0.05)
(Figure 2(c)).
3.2. Subnormothermic Perfusion and Antioxidant Status. Pre-
vious results show that the hepatic GSH [36] and the hepatic
reduced/oxidized glutathione ratio (GSH/GSSG) increased
in hypothermic rats [43] and in ex vivo subnormothermic
rat liver [9]. Therefore, we measured the levels of oxidized
and reduced glutathione and the activities of the enzyme
responsible for the formation of reduced glutathione, glu-
tathione reductase (GSH-R). No differences were observed
in GSH levels, GSH/GSSG ratio, and GSH-R activity at 26∘C
(Figures 3(a), 3(b), and 3(c)). However, at 22∘C GSH and the
GSH/GSSG ratio rised, and the activity of GSH-R increased
by 18%.
3.3. Subnormothermic Perfusion Increased the Activity of
Cathepsin B and Cathepsin L. The largest group of hydrolases
in lysosomal compartments are the cathepsin proteases.
Investigation of two cathepsins, B and L, showed that the
enzymatic activity of these proteases increased by 26-27% in
subnormothermic livers perfused at 22∘C (𝑃 < 0.05) (Figures
4(a) and 4(b)) compared to the normothermic group (37∘C)
suggesting that the lysosomal activity is increased.
3.4. Subnormothermic Perfusion Increased Ubiquitinated Pro-
teins and the Activity of 26S Proteasomes. Investigation of the
three proteolytic activities of the proteasome, the caspase-
like 𝛽1, trypsin-like 𝛽2, and chymotrypsin-like 𝛽5 activities,
indicated that proteasome activity was increased. While the
26S (ATP-dependent) caspase-like and trypsin-like activities
were not significantly affected by the subnormothermic
perfusion (Figures 5(a) and 5(b)), the chymotrypsin-like
proteasome activity was significantly increased at 26∘C (46%)
and at 22∘C (42%) (𝑃 < 0.01) (Figure 5(c)). This is especially
interesting since the expression of several 20S core subunits
(Figure 6(b)) and the expression of Rpt1 ATPase of the
19S proteasome subunit (Figure 6(a)) were not affected by
subnormothermic perfusion. These results suggest that the
increased proteasome activitymay be due to posttranslational
modifications or changes in the levels of associating partners
on the proteasomes rather than its expression. We have
previously shown that proteasomes from different tissues
have different levels of associating partners which can affect
proteasome activity [39].
To determine if the levels of polyubiquitinated proteins
are affected by subnormothermic perfusion we utilized west-
ern blotting and observed that subnormothermic perfusion
resulted in increased levels of polyubiquitinated proteins
(Figure 6(c), 𝑃 < 0.001). Since ubiquitinated proteins are
selectively degraded by the 26S proteasome and Rpt6 S120
phosphorylation has been shown to increase 26S proteasome
activity [44], the levels of Rpt6 S120 phosphorylation were
investigated. A significant increase in the ratio of phospho-
Rpt6/Rpt6-ATPase of the 19S proteasome subunit, from 0.59±
0.06 at normothermia to 1.06 ± 0.09 (𝑃 < 0.05) at 26∘C and
1.24±0.1 (𝑃 < 0.01) at 22∘C (Figure 6(d)), was detected.These
results suggest that the increased activity of the proteasome
that occurs with subnormothermic perfusion may be due to
increased phosphorylation of the serine 120 subunit of Rpt6.
4. Discussion
There is widespread consensus that treatment with hypother-
mia protects against various types of damage in many organs
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Figure 2: Lipid and protein oxidation in isolated perfused rat livers. IPR livers were perfused in a nonrecirculating system with Krebs-
Henseleit buffer at 37∘C for 15min, for stabilisation, and then at the indicated temperatures for 15minmore. Lipid peroxidation wasmeasured
as TBARS (a) and bywestern blotting ofHNE-protein adducts (b), and advanced oxidation protein products (dityrosine-containing and cross-
linking protein products) measured spectrophotometrically at 340 nm (c). Values expressed as mean ± SEM of 𝑛 = 6. Significant differences
from livers perfused at 37∘C: ∗𝑃 < 0.05. Significant differences from livers perfused at 26∘C: ++𝑃 < 0.01.
[25, 45–47]. Even so, the early events triggered by hypother-
mic treatment are not yet well defined. Potential mechanisms
suggested for such protection include reduction of oxida-
tive stress [16], increased endogenous antioxidants [17, 18],
reduction of inflammatory mediators [48], and decreased
apoptosis [49]. These effects of hypothermia, together with
the improved viability seen in subnormothermic perfused
livers [7, 9, 12], lead us to consider whether perfusion at
subnormothermic temperatures for a limited period of time
could trigger antioxidant mechanisms that confer cellular
protection.
The present study demonstrated that liver integrity was
retained at subnormothermic temperatures despite increased
lipid and protein oxidation levels. Preserved cellular integrity
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Figure 3: Temperature effects on antioxidant status in isolated perfused rat livers. IPR livers were perfused at 37∘C for 15min and then at
the indicated temperatures for 15min more. Bar graphs show hepatic GSH (a), GSH/GSSG ratio (b), and GSH-reductase activity (c). Values
expressed as mean ± SEM of 𝑛 = 6. Significant differences from livers perfused at 37∘C: ∗𝑃 < 0.05, ∗∗𝑃 < 0.01, and ∗∗∗𝑃 < 0.001. Significant
differences from livers perfused at 26∘C: ++𝑃 < 0.01 and +++𝑃 < 0.001.
was reflected by lowALT levels in the perfusate and increased
NO in the liver. Increased synthesis of NO has been shown to
be protective, as it reduces neutrophil adhesion and platelet
aggregation while preventing microcirculatory disturbances
in liver blood flow [50, 51]. NOhas also been proposed to play
a key role in both initiating andmediating ischemic precondi-
tioning [30] and is involved in the preconditioning response
for ischemia-reperfusion injury in fatty livers [50, 52].Despite
these protective effects, we alsomeasured increased oxidation
levels: lipid peroxidation, such as malondialdehyde MDA
(measured as TBARS) and protein oxidation (measured by
AOPP and HNE-protein adducts) were increased in subnor-
mothermic perfused livers.
Although some results showed that in liver the protein
expression of antioxidant enzymes and their activity were
relatively unaffected by one hour of cold exposure in rats
[53] and in hibernating animals [54], the GSH reductase
activity was previously shown to significantly increase after
cold exposure in rat livers [55]. Furthermore, the hepaticGSH
[36] and reduced/oxidized glutathione ratio (GSH/GSSG)
[9, 43] were shown to increase after one to six hours at
subnormothermic temperature in rats. However, the early
effects of brief exposure to subnormothermic temperature
on antioxidant enzymes have not been previously reported.
In the present work we found increased levels of GSH, the
GSH/GSSG ratio, and the activity of GSH-R in livers perfused
at 22∘C during 15min. Although increased levels of GSH and
GSH-R activity suggest increased antioxidant capability of
the liver, the increased levels of lipid and protein oxidation
suggest that the higher antioxidant capacity is at least initially
unable to completely prevent lipid peroxidation and the
resulting protein damage.
The lipid peroxidation process is a chain reaction that
produces multiple breakdown molecules, such as the alde-
hydes MDA and 4-HNE [56]. 4-HNE appears to be the
most toxic product of lipid peroxidation [57]. 4-HNE can
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Figure 4: Lysosomal activity in isolated perfused rat livers. IPR livers were perfused at 37∘C for 15min and then at the indicated temperatures
for 15min more. To independent lysosomal enzymes, cathepsin B (a) and cathepsin L (b) were measured to determine if lysosomal activity
was affected. Data is expressed as mean ± SEM of 𝑛 = 6. Significant differences from livers perfused at 37∘C: ∗𝑃 < 0.05. Significant differences
from livers perfused at 26∘C: +𝑃 < 0.05.
modify proteins by forming covalent adducts, accelerating
protein aggregation [42]. Oxidative modifications of proteins
can affect their physiological activity and typically increase
their degradation rate. Several reports have highlighted that
mild oxidation of proteins increases their susceptibility to
proteasomal degradation [58, 59]. The excessive accumula-
tion of such abnormal proteins can exacerbate the apoptotic
or necrotic pathways in the cell [60]. As such, removing
abnormal proteins may prevent oxidative stress induced cell
death. This function, largely due to the proteasome, has been
suggested to be part of the antioxidant defense [26].
The mechanisms by which lipid peroxidation modified
proteins are removed from the cell have been studied in
different models. 4-HNE exposure increases ubiquitination
of adiponectin [61] and the UPS was shown to be the
predominant proteolytic enzyme involved in the removal of
4-HNE adducts of alcohol dehydrogenase [62]. In kidney
homogenates, HNE-modified proteins were shown to be
specifically degraded by the UPS [63]. However, in lens
epithelial cells, HNE-modified proteins are ubiquitinated but
degraded by the ubiquitin-dependent lysosomal pathway
rather than by the proteasome [64]. Moreover, electron
micrographs of 4-HNE-treated cells showed extensive vac-
uolization and treatment with lysosomal inhibitors induced
cell death. These findings suggest that lipid peroxidation-
derived aldehydes also stimulate autophagy [65]. The present
study implicates elevated activity in both the UPS and
lysosomal pathways.
The lysosome system in the liver is involved in the degra-
dation of membrane-bound or organelle-associated proteins
and aggregates. The largest group of hydrolases in lysosomal
compartments are the cathepsin proteases, essential for the
proteolysis of protein substrates [66]. Cathepsins are respon-
sible for intracellular degradation of AdvancedGlycation End
Products- (AGEs-) modified proteins [67] and following oral
administration of AGEs, upregulation of cathepsins B and L
activities was reported in Drosophila melanogaster [68]. In
our model, isolated liver perfusion at 22∘C (but not at 26∘C)
resulted in increased activity of the two lysosomal proteases
investigated (cathepsins B and L) when compared to con-
trol temperatures (37∘C). This increased lysosomal activity
may be important in limiting lipid peroxidation damage
and removing some of the oxidized proteins (HNE-protein
adducts and AOPP). Increased lysosomal activity (lysosomal
degradation of autophagosomes) has been shown to protect
cardiac myocytes against ischemia/reperfusion injury [69].
Hence it is possible that the increased lysosomal activity at
22∘C may be protective against ischemia/reperfusion injury.
Oxidized proteins can also be removed by the protea-
some [37, 59] via ubiquitin independent degradation as well
as ubiquitin tagging and subsequent targeting by the 26S
proteasome [28]. Conversely, it has been suggested that an
excess of HNE may directly form adducts on the three
proteolytic subunits of the proteasome, thereby reducing its
enzymatic activity and contributing to the accumulation of
modified proteins [70]. Oxidative damage to various subunits
of the 26S proteasome during ischemia and reperfusion has
also been reported [60]. Seemingly in support of this data,
we observed higher levels of polyubiquitinated proteins at
26∘C and 22∘C when compared to 37∘C. Similarly, ubiquitin
conjugated proteins increased 2-3-fold during torpor in the
liver of hibernating squirrels [71].
The intact 26S proteasome is composed of one or two
19S regulatory particles at each end of a cylindrical 20S
core particle. Each protein particle has a complex quaternary
structure consisting of many (19–28) subunits. Degradation
of protein substrates requires the 19S particle to recognize
the ubiquitin-conjugated protein and regulate the entry of
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Figure 5: Proteasomal activity of 26S proteasome in isolated perfused rat livers. IPR livers were perfused at 37∘C for 15min and then at the
indicated temperatures for 15minmore.The caspase-like 𝛽1 (a), trypsin-like 𝛽2 (b), and chymotrypsin-like 𝛽5 (c) activities of the proteasome
were determined. Data is expressed as mean ± SEM of 𝑛 = 6. Significant differences from livers perfused at 37∘C: ∗∗𝑃 < 0.01.
the substrate in the proteolytic cavity of the 20S core particle.
The expression of several 20S and 19S subunits of the protea-
some was not affected by subnormothermic temperature in
our study, indicating no effect on the number of proteasomes
assembled. However, we found a significant increase in the
phosphorylation of the 19S subunit Rpt6 at serine 120. Previ-
ous studies have revealed that phosphorylation of proteasome
subunit Rpt6 increases 26S proteasome activity and that Rpt6
phosphorylationmay be an important regulatorymechanism
for proteasome-dependent control [44, 72, 73]. Covalent
regulation via phosphorylation allows for a quick increase
in the activity of the UPS independent of increasing the
overall number of proteasomes. Consistent with an increase
in the levels of phosphorylated Rpt6, the 26S chymotrypsin-
like activity of the proteasome was significantly increased
in livers perfused at both 26∘C and 22∘C subnormothermic
temperatures. Considering these results and the findings that
ischemic preconditioning also enhances proteasome function
[74], it seems probable that the increased proteasome activity
is protective. Additionally, elevated proteasome activity has
been shown to be associated with long-lived humans (cente-
narians) [75] and very long-lived animals such as the naked
mole rat [76].
5. Conclusions
Overall, our results suggest that the early events initiated
by hypothermia include the induction of oxidative stress
and concurrent stimulation of several potential mechanisms
of cell protection, including increased NO and GSH levels
and the activation of lysosomal and proteasomal systems to
repair oxidative damage. The increased proteasomal activity
is likely due, in part, to phosphorylation of serine 120 on the
proteasome Rpt6 subunit. Hypothermia may be acting as a
preconditioning stimulus which could explain its protective
role against ischemic, hypoxic, and toxic damage.
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Figure 6: Expression of ubiquitin proteasome system in isolated perfused rat livers. IPR livers were perfused at 37∘C for 15min and then at
the indicated temperatures for 15min more. Results show western blots and densitometric analysis for Rpt1 19S (a) and 20S core subunit (b).
(c) Levels of polyubiquitinated proteins; densitometry includes all polyubiquitinated bands detected. 𝛽-Actin was used as a normalization
control for the western blots. (d) Ponceau S (total protein) staining was used as loading control for phospho S120 Rpt6 and Rpt6 densitometric
analyses ofwestern blots; valueswere then used to calculate p-Rpt6/Rpt6 ratios. Results are expressed asmean± SEMof 𝑛 = 3 to 6 independent
samples per group. Significant differences from livers perfused at 37∘C: ∗𝑃 < 0.05, ∗∗𝑃 < 0.01, and ∗∗∗𝑃 < 0.001.
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